Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi

NCT03160183 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.

NCT NCT03160183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03160183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Phase
Observational
Overall status
Completed
Start date
September 30, 2016
Completion date
October 1, 2020
Enrollment
157 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, kaposi sarcoma